Pulmonx Corp (NASDAQ: LUNG) kicked off on Tuesday, up 26.92% from the previous trading day, before settling in for the closing price of $1.56. Over the past 52 weeks, LUNG has traded in a range of $1.47-$9.37.
Annual sales at Healthcare sector company slipped by -19.80% over the past five years. While this was happening, its average annual earnings per share was recorded -7.31%. With a float of $36.05 million, this company’s outstanding shares have now reached $40.74 million.
Pulmonx Corp (LUNG) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Medical Devices Industry. The insider ownership of Pulmonx Corp is 11.54%, while institutional ownership is 84.46%. The most recent insider transaction that took place on Sep 02 ’25, was worth 15,437. In this transaction PRESIDENT AND CEO of this company sold 9,648 shares at a rate of $1.60, taking the stock ownership to the 358,967 shares. Before that another transaction happened on Sep 02 ’25, when Company’s Chief Financial Officer & PAO sold 7,936 for $1.60, making the entire transaction worth $12,698. This insider now owns 208,489 shares in total.
Pulmonx Corp (LUNG) Latest Financial update
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.36 earnings per share (EPS), higher than consensus estimate (set at -0.44) by 0.08. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.39 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -7.31% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 13.01% during the next five years compared to -19.80% drop over the previous five years of trading.
Pulmonx Corp (NASDAQ: LUNG) Trading Performance Indicators
Take a look at Pulmonx Corp’s (LUNG) current performance indicators. Last quarter, stock had a quick ratio of 4.62. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.89.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.43, a number that is poised to hit -0.42 in the next quarter and is forecasted to reach -1.39 in one year’s time.
Technical Analysis of Pulmonx Corp (LUNG)
Pulmonx Corp (NASDAQ: LUNG) saw its 5-day average volume 22.53 million, a positive change from its year-to-date volume of 0.97 million. As of the previous 9 days, the stock’s Stochastic %D was 43.52%.
During the past 100 days, Pulmonx Corp’s (LUNG) raw stochastic average was set at 21.16%, which indicates a significant decrease from 33.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1569 in the past 14 days, which was lower than the 0.1775 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6742, while its 200-day Moving Average is $3.9844. Nevertheless, the first resistance level for the watch stands at $2.6267 in the near term. At $3.2733, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.6567. If the price goes on to break the first support level at $1.5967, it is likely to go to the next support level at $1.2133. The third support level lies at $0.5667 if the price breaches the second support level.
Pulmonx Corp (NASDAQ: LUNG) Key Stats
The company with the Market Capitalisation of 80.68 million has total of 40,747K Shares Outstanding. Its annual sales at the moment are 83,790 K in contrast with the sum of -56,390 K annual income. Company’s last quarter sales were recorded 23,860 K and last quarter income was -15,170 K.
